Calcium Channel Blockers Prevent Delayed Cerebral Ischemia After Intracranial Aneurysmal Subarachnoid Hemorrhage

  • J. S. Meyer
  • S. Takashima
  • Y. Terayama
Conference paper


Calcium entry blockers stabilize voltage-dependent calcium channels within cell membranes and prevent abnormal intracellular entry of calcium (Ca2+) through endothelial and ischemic neuronal cell membranes [9, 30]. It is well known that when Ca2+ ions enter vascular smooth muscle, contraction results, but if calcium entry is blocked by calcium antagonists, vascular dilatation occurs. It is also well known that when extracellular Ca2+ moves into ischemic neurones, neuronal function initially becomes impaired, eventually followed by neuronal death as excessive intracellular Ca2+ interferes with intracellular messengers and mitochondrial metabolism [31]. Experimental studies of cerebral ischemia in animal models have shown that pretreatment with the calcium entry antagonist nimodipine results in protection of the brain from cerbral infarction by preventing calcium entry into ischemic neurones and glia [1].


Cerebral Ischemia Calcium Antagonist Acute Ischemic Stroke Intracranial Aneurysm Focal Cerebral Ischemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe K, Kogure K, Watanabe T (1988) Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN200-110). J Cereb Blood Flow Metab 8: 436–439PubMedCrossRefGoogle Scholar
  2. 2.
    Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellitis DE, Bertsch LA,Boisvert DPJ, Hundley MB, Johnson RK, Strom JoA, Transou CR (1983) Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308: 619–624PubMedCrossRefGoogle Scholar
  3. 3.
    Auer LM (1982) Cerebrovascular activity of the Ca-antagonist nimodipine. J Cereb Blood Flow Metab 2: 268Google Scholar
  4. 4.
    Baethmann A, Jansen M (1986) Possible role of calcium entry blockers in brain protection. Eur Neurol 25 Suppl 1: 102–114CrossRefGoogle Scholar
  5. 5.
    Berger JR, Busto R, Ginsberg MD (1984) Verapamil: failure of metabolic amelioration following global forebrain ischemia in the rat. Stroke 15: 1029–1032PubMedCrossRefGoogle Scholar
  6. 6.
    Bogousslavsky J, Regli F, Zumstein V, Kobberling W (1990) Double-blind study of nimodipine in non-severe stroke. Eur Neurol 30: 23–26PubMedCrossRefGoogle Scholar
  7. 7.
    Findlay JM, Macdonald RL, Weir BKA (1991) Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 3: 336–361PubMedGoogle Scholar
  8. 8.
    Fisher CM (1975) Clinical syndroms in cerebral thrombosis, hypertensive hemorrhage, and ruptured saccular aneurysm. Clin Neurol 22: 117–147Google Scholar
  9. 9.
    Gelmers HJ (1983) The role of calcium and the significance of calcium antagonists in some neurological and neurosurgical disease. Clin Neurol Neurosurg 85: 213–224PubMedCrossRefGoogle Scholar
  10. 10.
    Gelmers HJ, Gorter K, Weerdt CJ, Wiezer HJA (1988) A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318: 203–207PubMedCrossRefGoogle Scholar
  11. 11.
    Greenberg JH, Uematsu D, Araki N, Hickey WF, Reivich M (1990) Cytosolic free calcium during focal cerebral ischemia and the effects of nimodipine on calcium and histologic damage. Stroke 21 Suppl 4:IV72–IV77Google Scholar
  12. 12.
    Hakim AM (1986) Cerebral acidosis in focal ischemia. II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6: 676–683PubMedCrossRefGoogle Scholar
  13. 13.
    Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, Marchal G, Biel C, Pokrupa R, Diksic M, Meyer E, Gjedde A, Marrett S (1989) The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 9: 523–534PubMedCrossRefGoogle Scholar
  14. 14.
    Hakim A, Hogan M, Berger L, Gjedde A (1989) Activation of the calcium channels in focal cerebral ischemia. J Cereb Blood Flow Metab 9 Suppl l:sl4Google Scholar
  15. 15.
    Jacewicz M, Brint S, Tanabe J, Wang XJ, Pulsinelli WA (1990) Nimodipine pretreatment improves cerebral blood flow and reduces brain edema in conscious rats subjected to focal cerebral ischemia. J Cereb Blood Flow Metab 10: 903–913PubMedCrossRefGoogle Scholar
  16. 16.
    Kazda S, Garthoff B, Krause HP, Schlobßmann D (1982) Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Arzneimittelforschung 32: 331–338PubMedGoogle Scholar
  17. 17.
    Kramer G, Tettenborn B, Rothacher G, Hacke W, Busse O, Hornig CR, Aichner F, Ladurner G (1990) Nimodipine German Austrian stroke trial. Neurology 40 Suppl 1:415— 416Google Scholar
  18. 18.
    Kubo K, Yoshitake I, Kumada Y, Shuto K, Nakamizo N (1984) Radical scavenging action of flunarizine in rat brain in vitro. Arch Int Pharmacodyn Ther 272: 283–295PubMedGoogle Scholar
  19. 19.
    Langley MS, Sorkin EM (1989) Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37: 669 2699Google Scholar
  20. 20.
    Leblanc R, Feindel W, Yamamoto L, Milton JG, Frojmovic MM (1983) Reversal of acute experimental cerebral vasospasm by calcium antagonism with verapamil. Can J Neurol Sci 11: 42–47Google Scholar
  21. 21.
    Martinez-Vila E, Guillen F, Villanueva JA, Matias–Guiu J, Bigorra J, Gil P, Carbonell A, Martmez-Lage JM (1990) Placebo–controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke 21: 1023–1028Google Scholar
  22. 22.
    Mohamed AA, Gotoh O, Graham DI, Osborne KA, McCulloch J, Mendelow AD, Teasdale GM, Harper AM (1985) Effect of pretreatment with the calcium antagonist nim odipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18: 705–711PubMedCrossRefGoogle Scholar
  23. 23.
    Neil–Dwyer G, Mee E, Dorrance D, Lowe D (1987) Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 8 Suppl K: 41–47Google Scholar
  24. 24.
    Nowicki JP, MacKenzie ET, Young AR (1982) Brain ischemia. Calcium and calcium antagonists. Pathol Biol 30: 282–288Google Scholar
  25. 25.
    Ohman J, Servo A, Heiskanen O (1991) Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 74: 8–13PubMedCrossRefGoogle Scholar
  26. 26.
    Paci A, Ottaviano P, Trenta A, Iannone G, Santis LD, Lancia G, Moschini E, Carosi M, Amigoni S, Caresia L (1989) Nimodipine in acute ischemic stroke: a double–blind controlled study. Acta Neurol Scand 80: 282–286PubMedCrossRefGoogle Scholar
  27. 27.
    Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JDR, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A (1988) Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double–blind placebo–controlled trial. J Neurosurg 68: 505–517Google Scholar
  28. 28.
    Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir(Wien) 82: 110–114Google Scholar
  29. 29.
    Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, Foy PM, Humphrey PRD, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 298: 636–642Google Scholar
  30. 30.
    Robinson MJ, Teasdale GM (1990) Calcium antagonists in the management of subarachnoid haemorrhage. Cerebrovasc Brain Metab Rev 2: 205–226PubMedGoogle Scholar
  31. 31.
    Siesjö BK, Bengtsson F (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia: a unifying hypothesis. J Cereb Blood Flow Metab 9: 127–140PubMedCrossRefGoogle Scholar
  32. 32.
    The American Nimodipine Study Group (1992) Clinical trial of nimodipine in acute ischemic stroke. Stroke 23: 3–8CrossRefGoogle Scholar
  33. 33.
    Trust Study Group (1990) Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 336: 1205–1209CrossRefGoogle Scholar
  34. 34.
    Uematsu D, Greenberg JH, Hickey WF, Reivich M (1989) Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 20: 1531–1537PubMedCrossRefGoogle Scholar
  35. 35.
    Yamamoto M, Meyer JS, Naritomi H, Sakai F, Yamaguchi F, Terry S (1979) Noninvasive measurement of cerebral vasospasm in patients with subarachnoid hemorrhage. J Neurol Sci 43: 301–311PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • J. S. Meyer
    • 1
  • S. Takashima
    • 1
  • Y. Terayama
    • 1
  1. 1.Department of NeurologyBaylor College of Medicine, and Veterans Administration Medical CenterHoustonUSA

Personalised recommendations